• SENSEX 79,454.47
    -880.34 (--1.10%)
  • BANKNIFTY 53,595.25
    -770.40 (--1.42%)
  • TVS Holdings
    8,818.25 7,755.00(%)
  • Angel One
    2,253.00 1,942.00(%)
  • Mazagon Dock
    2,962.90 3,170.00(%)
  • Tata Motors
    710.85 1,179.05(%)
  • Nuvama Wealth
    6,031.50 7,647.95(%)
  • Bharat Dynamics
    1,595.00 1,794.70(%)
  • Yes Bank
    20.36 27.41(%)
  • Bharat Electron
    321.80 340.35(%)
  • Paras Defence
    1,476.00 1,592.75(%)
  • Larsen & Toubro
    3,477.55 3,963.00(%)
  • Cochin Shipyard
    1,491.70 2,977.10(%)
  • Suzlon Energy
    50.96 37.95(%)
  • Jio Financial
    242.15 198.60(%)
  • Apollo Micro Sys
    137.00 157.00(%)
  • Titan Company
    3,530.00 3,866.15(%)
  • Hind.Aeronautics
    4,578.95 5,675.00(%)
  • Reliance Industr
    1,372.05 1,115.55(%)
  • Adani Green
    854.50 758.00(%)
  • Canara Bank
    98.40 129.35(%)
  • Dixon Technolog.
    15,063.05 7,935.00(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Sandu Pharmaceuticals Ltd Pharmaceuticals - Indian - Formulations

  • Indian Private
  • BSE Code : 4291.0
  • ISIN : INE751D01014
48.50 -2 (-3.81%)
  • As on 09 May 2025 (EOD)

  • Today’s Low

    46.05

  • Today’s High

    48.50

  • Open

    46.05

  • Perv Close

    50.42

  • 52W Low

    43.75

  • 52W High

    69.50

Key Indicators

  • P/E(TTM)

    25.80

  • Mar.Cap (₹Cr.)

    46.86

  • Div & Yield %

    1.65

  • Book Value(₹)

    42.29

  • Debt-Equity Ratio

    -3.81

  • AGM Date

    09-May-2025

  • EPS

    1.88

  • P/E Ratio

    25.80

Financials Ratios

  • Debt-Equity Ratio

    0.00

  • Mar.Cap (₹Cr.)

    46.86

  • RONW (%)

    3.66

  • ROCE (%)

    5.33

Score Board

  • Equity (₹ in Cr.)

    9.66

  • BV (₹)

    42.30

  • Sales( ₹ in Cr.)

    67.28

  • NP (in Cr.)

    1.46

  • NP Var(%)

    -4.0

  • Div%

    8.0

  • CPS (₹)

    2.10

  • EPS (₹)

    1.50

  • Traded Value (₹ in Lakhs)

    48.71

  • 52 Week High

    69.50

  • 52 Week Low

    43.75

  • Price BSE

    50.0

  • Price NSE

    0.00

  • Market Capital( in Cr.)

    48.71

  • P/C Ratio

    23.60

  • P/E Ratio

    33.10

  • Price Vs.BV

    1.50

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar
INCOME :            
Sales Turnover 67.28 65.35 65.50 58.76 48.37 49.42
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 67.28 65.35 65.50 58.76 48.37 49.42
Other Income 0.42 0.33 0.08 0.19 0.45 0.57
Stock Adjustments -1.63 3.08 0.45 -3.39 1.03 1.57
Total Income 66.07 68.76 66.03 55.56 49.85 51.56
EXPENDITURE :            
Raw Materials 30.94 34.27 36.20 31.11 26.15 26.91
Power and Fuel Cost 0.41 0.39 0.34 0.33 0.33 0.33
Employee Cost 10.07 11.10 8.91 8.02 6.85 6.49
Other Manufacturing Expenses 6.35 6.19 5.98 5.21 4.22 4.03
Selling and Administration Expenses 15.24 13.75 11.45 8.31 10.28 10.79
Miscellaneous Expenses 0.34 0.25 0.19 0.24 0.12 0.36
Employee Benefit Expenses 10.07 11.10 8.91 8.02 6.85 6.49
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 63.35 65.94 63.08 53.21 47.95 48.90
Operating Profit 2.72 2.82 2.96 2.35 1.90 2.66
Interest 0.06 0.08 0.11 0.11 0.43 1.01
Gross Profit 2.66 2.74 2.85 2.24 1.47 1.65
Depreciation 0.58 0.52 0.53 0.56 0.55 0.64
Profit Before Tax 2.08 2.22 2.32 1.68 0.92 1.01
Current Tax 0.59 0.66 0.70 0.56 0.13 0.37
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.02 0.03 0.03 0.03 0.07 -0.02
Reported Net Profit 1.46 1.52 1.59 1.09 0.72 0.67
Extraordinary Items 0.00 0.00 0.00 0.00 0.00 0.00
Adjusted Net Profit 1.46 1.52 1.59 1.09 0.72 0.67
Adjustment below Net Profit 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance brought forward 7.70 6.68 4.97 3.27 2.41 1.61
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.57 0.51 -0.11 -0.61 -0.14 -0.14
P & L Balance carried down 8.59 7.70 6.68 4.97 3.27 2.41
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 8.00 0.00 7.50 5.00 0.00 0.00
Dividend Per Share(Rs) 0.80 0.00 0.75 0.50 0.00 0.00
Earnings Per Share-Unit Curr 1.51 1.58 1.80 1.38 1.02 0.94
Earnings Per Share(Adj)-Unit Curr 1.51 1.58 1.80 1.38 1.02 0.94
Book Value 42.02 40.62 30.71 29.63 28.22 40.66
Book Value(Adj)-Unit Curr 42.02 40.62 30.71 29.63 28.22 40.66

Shareholding Pattern

  • Promoter Group

    42.90%

  • Public Share Holding

    57.10%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 494,182 5.12 494,182 1
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 3,650,548 37.79 3,650,548 6
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 4,144,730 42.90 4,144,730 7
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 500 0.01 0 1
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 0 0.00 0 0
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 500 0.01 0 1
2] Non Institution
Bodies Corporate 1,828,283 18.92 1,819,383 51
Clearing Members 660 0.01 660 3
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 64,553 0.67 64,553 33
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 131,483 1.36 131,183 99
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 634,738 6.57 634,738 9
Individuals holding nominal share capital up to Rs. 1 lakh 2,833,193 29.33 2,042,143 10,079
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 1,100 0.01 1,100 2
Others 0 0.00 0 0
Sub Total 5,515,760 57.09 4,715,510 10,279
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 9,660,990 100.00 8,860,240 10,287

Company Background

Sandu Pharmaceuticals LtdPharmaceuticals - Indian - Formulations

  • Sandu Pharmaceuticals Ltd
  • BSE Code : 4291.0
  • ISIN : INE751D01014

  • Incorporation Year

    1985

  • Registered Office

    Plot No 25/26/29 & 30
    Pilerne Indl Estate Marra Bard, Bardez,
    Goa-403511

  • Telephone

  • FAX

  • Chairman

    Balaram Vishwanathan

  • Managing Director

    Umesh B Sandu

  • Company Secretary

    Pratika Mhambray

  • Auditor

    Dileep & Prithvi

  • Face Value

    10

  • Listing

    BSE

  • Registrar

    Sharex Dynamic (India) Pvt Ltd
    C-101 247 Park ,
    L B S Marg ,Vikhroli West
    Mumbai - Mumbai - 400083

Sandu Pharmaceuticals Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Sandu Pharma. 48.50 67.70 67.28 25.80 5.33
Abbott India 30,147.65 6,097.18 5,848.91 48.01 44.71
Astrazeneca Phar 7,992.35 1,330.33 1,295.53 206.04 33.26
P & G Health Ltd 5,030.35 1,166.89 1,151.26 35.30 39.76
Glaxosmi. Pharma 2,758.30 3,530.73 3,407.25 54.85 44.44
Cipla 1,478.50 17,645.00 16,574.34 25.35 20.10
Amrutanjan Healt 692.60 437.58 421.23 40.60 20.84
Guj. Themis Bio. 269.15 174.19 169.82 55.72 44.82
Fermenta Biotec. 258.90 315.24 307.09 24.54 4.10
Bliss GVS Pharma 112.05 638.96 605.46 25.64 11.19
Ambalal Sarabhai 35.20 11.70 3.81 15.04 1.92